Wang, Guanqun http://orcid.org/0000-0002-4465-9312
Li, Haoxuan
Ye, Chang http://orcid.org/0000-0003-0236-5671
He, Kayla
Liu, Shun
Jiang, Bochen http://orcid.org/0000-0001-6686-8847
Ge, Ruiqi http://orcid.org/0000-0002-8529-3070
Gao, Boyang http://orcid.org/0000-0002-6956-1450
Wei, Jiangbo http://orcid.org/0000-0003-2691-6490
Zhao, Yutao
Li, Aixuan
Zhang, Di http://orcid.org/0000-0003-2906-4684
Zhang, Jianhua http://orcid.org/0000-0002-3819-2437
He, Chuan http://orcid.org/0000-0003-4319-7424
Article History
Received: 19 January 2024
Accepted: 13 May 2024
First Online: 7 June 2024
Competing interests
: The authors have filed a provision patent application of the method reported in this paper through the University of Chicago. C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio, Inc. and Ellis Bio Inc., a scientific cofounder and equity holder of Accent Therapeutics, Inc., and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The remaining authors declare no competing interests.